NEW ANTIBIOTICS--ISOLATION, SYNTHESIS, AND EVALUATION
NEW ANTIBIOTICS--ISOLATION, SYNTHESIS, AND EVALUATION
批准号:
3125407
负责人:
Lester A. Mitscher
金额:
$20.24万
依托单位国家:
美国
项目类别:
财政年份:
1976
资助国家:
美国
项目状态:
已结题
起止时间:
1976-09-01 至 1991-08-31
关键词:
Mycobacterium Pseudomonas aeruginosa angiosperms antibacterial agents antibiotics antifungal agents antitubercular agents chemical structure function crystallization drug design /synthesis /production drug screening /evaluation gram negative bacteria laboratory mouse medicinal plants pharmacokinetics plant extracts quinoline
中文摘要
本研究的目的是研究存在于
高等植物提取物,以发现具有新的
结构和新的作用模式,并确定其潜力,
用于治疗人类感染性疾病。 新型抗生素是
特别是用来治疗当代棘手的疾病
目前的发酵抗生素还不能完全
由于毒性、低效力、微生物抗性,
药代动力学特性差等。 这一努力的核心是
是合适植物材料的获得和植物学鉴定,
提取、筛选一系列疾病指示生物,
在工业筛选程序中,生物测定定向分级,
物理化学结构测定、合成(如适用
结构澄清,大量制备,
结构-活性关系的优化等),评估的
体外抗菌谱和效力与已建立的
抗生素和在感染的实验动物中的体内评价。 的
后者通常由商业制药公司越位完成
拥有这项工作的特殊设施和专门知识。 在一些情况下
采用定向生物合成方法以制备
尤其是所需的靶分子。
目前,初级屏幕的重点是针对
革兰氏阳性菌和革兰氏阴性菌、结核菌、酵母菌和真菌,
假单胞菌 在第二次筛查中,性病微生物,厌氧菌,
检查军团菌和其他病原体。
英文摘要
The goal of this research is to study the antimicrobial agents present in
higher plant extracts in order to discover antibiotics with novel
structures and novel modes of action and to determine their potential for
use in treatment of human infectious diseases. Novel antibiotics are
especially sought for the treatment of contemporarily troublesome diseases
against which current fermentation-based antibiotics are not fully
satisfactory for reasons of toxicity, low potency, microbial resistance,
poor pharmacokinetic characteristics, and the like. Central to this effort
is the obtention and botanical identification of suitable plant material,
extraction, screening against a battery of disease indicator organisms used
in industrial screening programs, bioassay directed fractionation,
physico-chemical structure determination, synthesis (where indicated for
structural clarification, preparation of substantial quantities,
optomization of structure-activity relationships, etc.), evaluation of in
vitro antimicrobial spectrum and potency in comparison with established
antibiotics and in vivo evaluation in infected experimental animals. The
latter is usually done off-side by commercial pharmaceutical firms
possessing special facilities and expertise for this work. In some cases
directed biosynthetic methodology is employed in order to prepare
especially desired target molecules.
The present emphasis of the primary screen is activity against
Gram-positive and Gram-negative bacteria, tuberculosis, yeast and fungi and
pseudomonads. In secondary screens, venereal organisms, anaerobes,
Legionella and other pathogens are examined.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
COBRE: UKS: CORE C: MEDICINAL CHEMISTRY
-
批准号:7959397
-
项目类别:
-
资助金额:$31.0万
-
财政年份:2009
-
负责人:Lester A. Mitscher
-
依托单位:
COBRE: UKS: CORE C: MEDICINAL CHEMISTRY
-
批准号:7720081
-
项目类别:
-
资助金额:$30.55万
-
财政年份:2008
-
负责人:Lester A. Mitscher
-
依托单位:
COBRE: UKS: CORE C: MEDICINAL CHEMISTRY
-
批准号:7609706
-
项目类别:
-
资助金额:$37.56万
-
财政年份:2007
-
负责人:Lester A. Mitscher
-
依托单位:
ANTIMYCOBACTERIAL AGENTS FROM HIGHER PLANTS
-
批准号:2004155
-
项目类别:
-
资助金额:$17.7万
-
财政年份:1995
-
负责人:Lester A. Mitscher
-
依托单位:
ANTIMYCOBACTERIAL AGENTS FROM HIGHER PLANTS
-
批准号:2073061
-
项目类别:
-
资助金额:$17.43万
-
财政年份:1995
-
负责人:Lester A. Mitscher
-
依托单位:
ANTIMYCOBACTERIAL AGENTS FROM HIGHER PLANTS
-
批准号:2073062
-
项目类别:
-
资助金额:$17.03万
-
财政年份:1995
-
负责人:Lester A. Mitscher
-
依托单位:
ANTIMYCOBACTERIAL AGENTS FROM HIGHER PLANTS
-
批准号:2633552
-
项目类别:
-
资助金额:$18.4万
-
财政年份:1995
-
负责人:Lester A. Mitscher
-
依托单位:
DISCOVERY OF NOVEL FUNGICIDAL AGENTS
-
批准号:3547578
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1991
-
负责人:Lester A. Mitscher
-
依托单位:
DISCOVERY OF NOVEL EUNGICIDAL AGENTS
-
批准号:3547579
-
项目类别:
-
资助金额:$42.45万
-
财政年份:1991
-
负责人:Lester A. Mitscher
-
依托单位:
NOVEL ANTIMUTAGENIC COMPOUNDS
-
批准号:3186005
-
项目类别:
-
资助金额:$19.49万
-
财政年份:1989
-
负责人:Lester A. Mitscher
-
依托单位:
NOVEL ANTIMUTAGENIC COMPOUNDS
-
批准号:3186003
-
项目类别:
-
资助金额:$20.36万
-
财政年份:1989
-
负责人:Lester A. Mitscher
-
依托单位:
NOVEL ANTIMUTAGENIC COMPOUNDS
-
批准号:3186006
-
项目类别:
-
资助金额:$19.84万
-
财政年份:1989
-
负责人:Lester A. Mitscher
-
依托单位:
MEDICINAL CHEMISTRY AND PHARMACOLOGY
-
批准号:3537888
-
项目类别:
-
资助金额:$5.37万
-
财政年份:1979
-
负责人:Lester A. Mitscher
-
依托单位:
MEDICINAL CHEMISTRY AND PHARMACOLOGY
-
批准号:3537894
-
项目类别:
-
资助金额:$14.83万
-
财政年份:1979
-
负责人:Lester A. Mitscher
-
依托单位:
MEDICINAL CHEMISTRY AND PHARMACOLOGY
-
批准号:3537891
-
项目类别:
-
资助金额:$10.55万
-
财政年份:1979
-
负责人:Lester A. Mitscher
-
依托单位:
MEDICINAL CHEMISTRY AND PHARMACOLOGY
-
批准号:3537890
-
项目类别:
-
资助金额:$5.14万
-
财政年份:1979
-
负责人:Lester A. Mitscher
-
依托单位:
MEDICINAL CHEMISTRY AND PHARMACOLOGY
-
批准号:3537893
-
项目类别:
-
资助金额:$12.22万
-
财政年份:1979
-
负责人:Lester A. Mitscher
-
依托单位:
MEDICINAL CHEMISTRY AND PHARMACOLOGY
-
批准号:3537889
-
项目类别:
-
资助金额:$13.77万
-
财政年份:1979
-
负责人:Lester A. Mitscher
-
依托单位:
MEDICINAL CHEMISTRY AND PHARMACOLOGY
-
批准号:3537892
-
项目类别:
-
资助金额:$10.76万
-
财政年份:1979
-
负责人:Lester A. Mitscher
-
依托单位:
NEW ANTIBIOTICS--ISOLATION, SYNTHESIS, AND EVALUATION
-
批准号:2059962
-
项目类别:
-
资助金额:$22.09万
-
财政年份:1976
-
负责人:Lester A. Mitscher
-
依托单位:
国内基金
海外基金
登录
查看更多内容
生物质炭负载噬菌体对土壤中抗生素耐药菌(Pseudomonas aeruginosa)迁移阻控及靶向裂解的协同机制
-
批准号:42077106
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2020
-
负责人:孙明明
-
依托单位:
融合自组装双亲短肽提高Pseudomonas aeruginosa脂肪氧合酶热稳定性机制的研究
-
批准号:31401638
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2014
-
负责人:刘松
-
依托单位:
铜绿假单胞菌(Pseudomonas aeruginosa)SU8抑菌活性物质吩嗪-1-甲酰胺结构改造及增效作用研究
-
批准号:31301709
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:张亚
-
依托单位:
铜绿假单胞菌(Pseudomonas aeruginosa)作用下PBS及其共聚物的降解途径研究
-
批准号:21144008
-
项目类别:专项基金项目
-
资助金额:10.0万元
-
批准年份:2011
-
负责人:张敏
-
依托单位:
Pseudomonas aeruginosa长链烷烃羟化酶基因的研究
-
批准号:30870081
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2008
-
负责人:沈标
-
依托单位: